Omeros reported $-54792000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US USD -6739000 1.75M
Alnylam Pharmaceuticals ALNY:US USD -329357000 54.68M
Cytokinetics CYTK:US USD -142310000 122.49M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Insmed INSM:US USD -130773000 35.63M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Knight Therapeutics Inc GUD:CN CAD 851K 215K
Macrogenics MGNX:US USD -24813000 16.49M
Mirati Therapeutics MRTX:US USD -173307000 3.14M
Omeros OMER:US USD -54792000 13.1M
Pfizer PFE:US USD 10.67B 3.11B
Regulus Therapeutics RGLS:US USD -7551000 293K
Rockwell Medical RMTI:US USD -4190000 777K
Sangamo Biosciences SGMO:US USD -53125000 10.03M
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
United Therapeutics UTHR:US USD 312.5M 161.9M
Vital Therapies VTL:US USD -21224000 677K
Xoma XOMA:US USD -4178000 492K